Navigation Links
Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled
Date:6/30/2009

SAN DIEGO, June 30 /PRNewswire/ -- Accumetrics, Inc. announces that it has reached the halfway mark (1,600 patients) in the enrollment of its landmark clinical trial, GRAVITAS (Gauging Responsiveness with A VerifyNow(R) Assay Impact on Thrombosis And Safety). The trial is specifically designed to demonstrate the value of providing clinicians with actionable information for patients who are poor responders to clopidogrel (Plavix(R)). The multi-center, placebo controlled trial will determine whether tailored antiplatelet therapy for poor responders, identified based on the results of the company's VerifyNow P2Y12 Test, reduces major cardiovascular adverse events (e.g., heart attack, stent thrombosis) following percutaneous coronary intervention (PCI). Currently the trial is being conducted at more than 70 sites in the U.S. and Canada, with a total enrollment goal of approximately 2,800 patients.

"We are thrilled to have reached the halfway point for enrollment in our GRAVITAS trial," said Jeff Dahlen, Ph.D, Vice President, Clinical and Regulatory Affairs of Accumetrics, Inc. "Once complete, GRAVITAS will be the largest multi-center clinical trial that links testing with personalized medicine and improved patient outcomes. We continue our commitment to ensuring that the VerifyNow System is shown to be an integral tool in optimizing the use of antiplatelet therapy."

About GRAVITAS

The concept of variability in response to antiplatelet therapy has been well established. Also being demonstrated with increased frequency is the question of whether poor response to antiplatelet therapy, based on a laboratory test, leads to poor patient outcomes. However, Accumetrics recognizes the need for a study specifically designed to demonstrate the value of providing clinicians with actionable information to improve outcomes for those patients who are poor responders to antip
'/>"/>

SOURCE Accumetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections
2. AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain
3. Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech
4. Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obamas Announcement on Healthcare Reform
5. ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing and Whitepaper Availability on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Diseases
6. Spherix Announces Positive Phase 2 Study Results
7. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
8. GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
9. CoAxia, Inc. Announces $21.5M Series D Financing
10. Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs
11. Roskamp Institute Announces Enrollment of First Students to Participate in its Innovative Research Doctorate Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 19, 2014   Hospira, Inc. ... provider of injectable drugs and infusion technologies, today announced ... 33rd Annual Healthcare Conference on Wednesday, Jan. 14, 2015, ... is scheduled to begin at 10:30 a.m. Pacific time ... to all interested parties through a live audiocast accessible ...
(Date:12/19/2014)... Dec. 19, 2014  Monarch America Inc. (OTCQB: CANK) ... is pleased to provide this review of the Company,s ... 2015. "Over this past year, we achieved ... am extremely proud to say that Monarch America is ... it has ever been," stated Eric Hagen , ...
(Date:12/19/2014)... , Dec. 18, 2014 Somewhere between dropping ... health was forgotten. But Audicus , a next-generation ... better this new year. Hearing loss is ... aging population, though it is often unaddressed. Forty-eight million ... has a hearing aid, mainly due to price. Hearing ...
Breaking Medicine Technology:Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3Audicus Will Help People Resolve to Hear Better in 2015 2
... Calif., Feb. 25 InteKrin Therapeutics, Inc.,a ... the,development and commercialization of novel drugs for ... announced today that it has,initiated a Phase ... lead product,candidate INT131, a non-TZD SPPARM (Selective ...
... for Grants to Assist Men Who Have Sex With,Men ... In an ambitious move to,significantly bolster global HIV program ... for AIDS Research, has,announced the first recipients of funding ... will fund 17 grassroots and frontline,organizations in Africa, the ...
Cached Medicine Technology:InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131 2amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries 2amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries 3
(Date:12/20/2014)... New York, NY (PRWEB) December 20, 2014 ... ) that allege a metal-on-metal version of the ... move forward in state and federal courts, Bernstein ... in New Jersey’ Bergen County Superior Court on ... were permitted to begin deposition of plaintiffs on ...
(Date:12/20/2014)... The Doctor’s Office Urgent Care of Paramus, New Jersey has ... They’ve treated over 40,000 patients while carrying out their ... to the Paramus area. , For 2015, the practice ... of top-notch board certified physicians: Christine Milosis MD, Sandra Ugras ... doctors will work tirelessly to carry out The Doctor’s ...
(Date:12/20/2014)... The aftermath of the November 24th hack on Sony ... Hollywood, but worldwide. As reported in the Los ... attack are starting a finger-pointing game which could put some ... are not the only ones affected, regular employees who had ... times ahead, agents and lawyers could be in for some ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 The Twin ... protection education event in the nation! Over 250 financial ... the minute information on the industry, get motivated to ... of real people facing and overcoming the challenges of ... all across the nation came together to attend The ...
(Date:12/19/2014)... Montrose, Colorado (PRWEB) December 20, 2014 It’s ... many, travel is something that is put to the wayside ... those who still have that travel “itch” and that burning ... Inn Montrose accommodates families on their journey to Telluride with ... trip, get visitors to and from the resort, and ensure ...
Breaking Medicine News(10 mins):Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 3Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 5Health News:The 13th Annual Twin Cities DI Day Now On Video 2Health News:The 13th Annual Twin Cities DI Day Now On Video 3Health News:Days Inn Montrose Colorado Delivers Last Minute Holiday Season Ski Getaway Accommodations 2
... made using unusual metals could form an effective treatment against ... immunity to other drugs, according to research at the University ... study, published in the Journal of Medicinal Chemistry , ... metals Ruthenium and Osmium, which are found in the same ...
... norepinephrine, serotonin, and dopamine, are regulated a finding ... drugs for depression target the regulatory process for neurotransmitters, ... to work in other cases. Recent findings ... the brain, are key players in the management of ...
... ... informed on Swine Flu developments are part of the awareness strategy , ... Edmonton, AB (Vocus) October 18, ... up to date on all developments, says a school representative. , ,“We post the ...
... e cigarettes sales have generally been tobacco smoking individuals ... online sales associate for E-Cigarettes National, reports an influx ... loved ones that smoke. "Some of these callers are ... starter kit for their spouses or partners that have ...
... more likely the pain, says research led by an 11-year-old, , ... for more than an hour a day increase their chances of ... The lead author of the study knows this all too well. ... joint pain among his classmates at Rossman Elementary in St. Louis, ...
... more likely to die within a year of major ... -- Veterans with post-traumatic stress disorder face an increased ... is performed years after they have completed their service, ... on 1,792 male veterans who had major non-cardiac, non-emergency ...
Cached Medicine News:Health News:Metals could forge new cancer drug 2Health News:Reeves College Prepares Campuses for H1N1 Virus 2Health News:Online Sales of E Cigarettes Expected to Rise Over the Holidays 2Health News:Video Games Can Play Havoc With Kids' Joints 2Health News:Video Games Can Play Havoc With Kids' Joints 3Health News:Post-Traumatic Stress May Raise Death Risks 2
Features soft, low friction sheath that extends beyond the tip....
Facilitates intubation of tracheal tubes....
SunGlide™ Stylette - Green Adult. Use in 7.0 to 10mm tubes. 25/box....
Fiber Optic Stylette with Adjustable Stop 18., ,Fiber optic handles require two AA batteries not included....
Medicine Products: